These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22626929)

  • 1. Novel AAV-based genetic vaccines encoding truncated dengue virus envelope proteins elicit humoral immune responses in mice.
    Li X; Cao H; Wang Q; Di B; Wang M; Lu J; Pan L; Yang L; Mei M; Pan X; Li G; Wang L
    Microbes Infect; 2012 Sep; 14(11):1000-7. PubMed ID: 22626929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel adeno‑associated virus‑based genetic vaccines encoding hepatitis C virus E2 glycoprotein elicit humoral immune responses in mice.
    Zhu F; Wang Y; Xu Z; Qu H; Zhang H; Niu L; Xue H; Jing D; He H
    Mol Med Rep; 2019 Feb; 19(2):1016-1023. PubMed ID: 30569131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
    Khanam S; Pilankatta R; Khanna N; Swaminathan S
    Vaccine; 2009 Oct; 27(43):6011-21. PubMed ID: 19665609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF.
    Raviprakash K; Marques E; Ewing D; Lu Y; Phillips I; Porter KR; Kochel TJ; August TJ; Hayes CG; Murphy GS
    Virology; 2001 Nov; 290(1):74-82. PubMed ID: 11883007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen.
    Apt D; Raviprakash K; Brinkman A; Semyonov A; Yang S; Skinner C; Diehl L; Lyons R; Porter K; Punnonen J
    Vaccine; 2006 Jan; 24(3):335-44. PubMed ID: 16125280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of neutralizing antibodies and T cell responses by dengue virus type 2 envelope domain III encoded by plasmid and adenoviral vectors.
    Khanam S; Khanna N; Swaminathan S
    Vaccine; 2006 Oct; 24(42-43):6513-25. PubMed ID: 16860446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of chimeric DNA vaccines consisting of premembrane and envelope genes of Japanese encephalitis and dengue viruses as a strategy for reducing induction of dengue virus infection-enhancing antibody response.
    Sjatha F; Kuwahara M; Sudiro TM; Kameoka M; Konishi E
    Microbiol Immunol; 2014 Feb; 58(2):126-34. PubMed ID: 24372832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of dengue 2 envelope domain III in plant using TMV-based vector system.
    Saejung W; Fujiyama K; Takasaki T; Ito M; Hori K; Malasit P; Watanabe Y; Kurane I; Seki T
    Vaccine; 2007 Sep; 25(36):6646-54. PubMed ID: 17659815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice.
    Kochel T; Wu SJ; Raviprakash K; Hobart P; Hoffman S; Porter K; Hayes C
    Vaccine; 1997 Apr; 15(5):547-52. PubMed ID: 9160523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of immunity and protective efficacy of a dengue-3 pre-membrane and envelope DNA vaccine in Aotus nancymae monkeys.
    Blair PJ; Kochel TJ; Raviprakash K; Guevara C; Salazar M; Wu SJ; Olson JG; Porter KR
    Vaccine; 2006 Feb; 24(9):1427-32. PubMed ID: 16214271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein.
    Raviprakash K; Kochel TJ; Ewing D; Simmons M; Phillips I; Hayes CG; Porter KR
    Vaccine; 2000 May; 18(22):2426-34. PubMed ID: 10738100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA priming E and NS1 constructs--homologous proteins boosting immunization strategy to improve immune response against dengue in mice.
    Mellado-Sánchez G; García-Cordero J; Luria-Pérez R; Lázaro-Olan L; Santos-Argumedo L; Gutiérrez-Castañeda B; Estrada-García I; Cedillo-Barrón L
    Viral Immunol; 2005; 18(4):709-21. PubMed ID: 16359237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: their immunity and protective efficacy in mice.
    Lu H; Xu XF; Gao N; Fan DY; Wang J; An J
    Mol Immunol; 2013 Jun; 54(2):109-14. PubMed ID: 23270684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a DNA vaccine candidate expressing prM-E-NS1 antigens of dengue virus serotype 1 with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in immunogenicity and protection.
    Zheng Q; Fan D; Gao N; Chen H; Wang J; Ming Y; Li J; An J
    Vaccine; 2011 Jan; 29(4):763-71. PubMed ID: 21095256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Adeno-Associated Virus-Based Genetic Vaccine Encoding the Hepatitis C Virus NS3/4 Protein Exhibits Immunogenic Properties in Mice Superior to Those of an NS3-Protein-Based Vaccine.
    Zhu F; Chen T; Zhang Y; Sun H; Cao H; Lu J; Zhao L; Li G
    PLoS One; 2015; 10(11):e0142349. PubMed ID: 26556235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes.
    Putnak R; Fuller J; VanderZanden L; Innis BL; Vaughn DW
    Am J Trop Med Hyg; 2003 Apr; 68(4):469-76. PubMed ID: 12875299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA immunization of mice and macaques with plasmids encoding hepatitis C virus envelope E2 protein expressed intracellularly and on the cell surface.
    Forns X; Emerson SU; Tobin GJ; Mushahwar IK; Purcell RH; Bukh J
    Vaccine; 1999 Apr; 17(15-16):1992-2002. PubMed ID: 10217599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties.
    Liu Y; Zhou J; Yu Z; Fang D; Fu C; Zhu X; He Z; Yan H; Jiang L
    BMC Microbiol; 2014 Dec; 14():233. PubMed ID: 25520151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of a Candidate DNA Vaccine Based on the prM/E Genes of a Dengue Type 2 Virus Cosmopolitan Genotype Strain.
    Putri DH; Sudiro TM; Yunita R; Jaya UA; Dewi BE; Sjatha F; Konishi E; Hotta H; Sudarmono P
    Jpn J Infect Dis; 2015; 68(5):357-63. PubMed ID: 25766602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of tetravalent protective immunity against four dengue serotypes by the tandem domain III of the envelope protein.
    Chen S; Yu M; Jiang T; Deng Y; Qin C; Qin E
    DNA Cell Biol; 2007 Jun; 26(6):361-7. PubMed ID: 17570760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.